netFormulary Northern Lincolnshire NHS
Formulary  
 Search
 Formulary Chapter 3: Respiratory system - Full Chapter
Chapter Links...
 Details...
03.02  Expand sub section  Corticosteroids
Beclometasone (Clenil Modulite®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Beclometasone (Qvar®kelhale®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Beclometasone and formoterol (Fostair NEXThaler®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Beclometasone and formoterol (Fostair®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
Link  NICE Evidence summary [ESNM47]: Chronic obstructive pulmonary disease: beclometasone/formoterol (Fostair)
   
Beclometasone, Formeterol and Glycopyrronium (Trimbow®)
(Other inhalers)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

Triple dose inhaler available as a pressurised metered dose inhaler delivering a solution with a nominal dose per actuation of 87 micrograms beclometasone dipropionate, 5 micrograms formoterol fumarate dihydrate and 9 micrograms glycopyrronium 

 
   
Budesonide
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Green

Easyhaler, dry powder inhalation

Amber Nebules -acute treatment of croup

 
   
Budesonide and formoterol (DuoResp Spiromax®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Budesonide and formoterol (Fobumix Easyhaler®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

easyhaler

 
   
Budesonide and formoterol (Symbicort®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Fluticasone furoate & vilanterol (Relvar Ellipta®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
Link  NICE Evidence Summary [ESNM34]: Asthma: fluticasone furoate/vilanterol (Relvar Ellipta) combination inhaler
   
Fluticasone furoate, umeclidinium & vilanterol (as trifenatate) (trelegy ®)
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green

 

Trelegy Ellipta 92 micrograms/55 micrograms/22 micrograms inhalation powder (pre-dispensed) contains the following:

Each single inhalation provides a delivered dose (the dose leaving the mouthpiece) of 92 micrograms fluticasone furoate, 65 micrograms umeclidinium bromide equivalent to 55 micrograms umeclidinium and 22 micrograms vilanterol (as trifenatate). This corresponds to a pre-dispensed dose of 100 micrograms fluticasone furoate, 74.2 micrograms umeclidinium bromide equivalent to 62.5 micrograms umeclidinium and 25 micrograms vilanterol (as trifenatate).

 
   
Fluticasone propionate and formoterol (Flutiform®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Red

children between 12-18 where sirdupla is not licenced

 
   
Fluticasone propionate and salmeterol (AirFluSal Forspiro® )
View adult BNF View SPC online View childrens BNF  Track Changes
Formulary
Green
 
   
Fluticasone propionate and salmeterol (Sirdupla®, Seretide®)
View adult BNF View SPC online View childrens BNF  Track Changes
Restricted Drug Restricted
Amber

Green Restricted ItemSeretide 50 Evohaler * Paediatric use only

Amber Seretide Evohaler and Accuhaler.
Restricted to use in asthma not to be used as new initiation for COPD   

 
   
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Green

Green -Medicines suitable for routine use within primary care and Secondary care Can be initiated within primary care within their licensed indication, in accordance with nationally recognised formularies  

Amber

Amber- Medicines suitable to be prescribed in primary care after specialist /Consultant recommendation or initiation. A supporting prescribing guideline may be requested which must have been agreed by the relevant secondary care trust Medicines and Therapeutic Committee and approved by the Area Prescribing Committee.   

Red

Red-Hospital initiation and continuation only  

Amber Shared Care Protocol

AMBER SHARE CARE PROTOCOL- Medicines that should be initiated by a specialist and prescribed by primary care prescribers only under a shared care protocol, once the patient has been stabilised  

Blue

To be supplied from the appropriate commissioned provider.   

Green 2

GREEN 2- to be prescribed by primary care only   

Grey

GREY- NON FORMULARY (As agreed by Area Prescribing Committee)  

netFormulary